Sat, Aug 30, 2014, 9:39 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • l40characters l40characters Jan 22, 2014 9:59 AM Flag

    Podhaler tobi pitch= will dwarf Arikace in worldwide sales for Cys fibrosis.

    The pitch is about the podhaler not Insmed price or non-tuberculous mycobacterial . Arikace will be a weak competitor in the Cys Fibrosis market. Europe has the podhaler in the recommended first tier. In 2 years when Arikace finally {if} gets to market it will be just another entry.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • michael_coen@ymail.com michael_coen Jan 22, 2014 10:21 AM Flag

      well guess what:
      [1] many of the podhaler users are irritated by the DRY powder (they can't take it / makes them cough too much, and the dry powder does not penetrate deep into the lungs;
      [2] the exact same Pari base until is installed in most EU CF patients' homes already (thanks to Cayston for that); just pop in the Arikace nebulizer and off you go... once/day job done.

 
INSM
13.93+0.11(+0.80%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Synaptics Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Burger King Worldwide, Inc.
NYSEFri, Aug 29, 2014 4:02 PM EDT